Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Fury, M.D.

Concepts (247)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Squamous Cell29201839112.940 Why?
Head and Neck Neoplasms24201925152.540 Why?
Oropharyngeal Neoplasms1020173921.430 Why?
Radiotherapy, Intensity-Modulated820157341.380 Why?
Cisplatin10201516881.370 Why?
Antineoplastic Combined Chemotherapy Protocols212017106131.150 Why?
Antibodies, Monoclonal9201997780.980 Why?
Neoplasms, Squamous Cell320111050.870 Why?
Papillomaviridae3201710190.760 Why?
Neoplasms, Connective and Soft Tissue12017250.730 Why?
Limbic Encephalitis12017400.720 Why?
Neoplasm Proteins4201538010.680 Why?
Maximum Tolerated Dose920179170.660 Why?
Sirolimus6201715840.620 Why?
Chondrosarcoma120172940.610 Why?
Eukaryotic Initiation Factor-4E220131240.540 Why?
Antineoplastic Agents112018135980.530 Why?
Tonsillar Neoplasms42011580.510 Why?
Neoplasm Recurrence, Local8201481580.500 Why?
Guanine220102840.480 Why?
Glutamates220104070.480 Why?
Carcinoma, Basal Cell120164930.470 Why?
Drug Administration Schedule9201751900.460 Why?
Quinazolines2201114300.460 Why?
Benzodioxoles12011560.440 Why?
Granulocyte Colony-Stimulating Factor320156220.430 Why?
TOR Serine-Threonine Kinases5201320500.420 Why?
Taxoids320137040.410 Why?
Antibiotics, Antineoplastic320137780.400 Why?
Skin Neoplasms2201852020.390 Why?
Paclitaxel5201716440.380 Why?
Deoxycytidine220108710.380 Why?
Disease-Free Survival10201870800.360 Why?
Neoplasm Staging92018110450.350 Why?
Neoplasms82017184760.350 Why?
Dose-Response Relationship, Drug92018115840.340 Why?
Carboplatin620178010.320 Why?
Antibodies, Bispecific120071110.320 Why?
Autoimmune Diseases1201720380.320 Why?
Carcinoma3201323400.310 Why?
Aged3920191569370.290 Why?
Middle Aged3920192107470.260 Why?
Doxorubicin2201122330.260 Why?
Hemangiosarcoma120052340.260 Why?
Potassium Channels, Calcium-Activated12002470.250 Why?
Tumor Burden4201219010.240 Why?
Neoplasm Metastasis5201652940.240 Why?
Male4520193439170.240 Why?
Adult3220192062950.230 Why?
Aminopterin22014180.220 Why?
Antineoplastic Agents, Phytogenic120056510.220 Why?
Female4420193651990.210 Why?
Angiogenesis Inhibitors2201321040.210 Why?
Positron-Emission Tomography7201257270.210 Why?
Injections, Intravenous2201315500.200 Why?
Tongue Neoplasms420141790.200 Why?
Cyclin-Dependent Kinase Inhibitor p16220147070.200 Why?
Pyrroles1200611970.200 Why?
Vitamin B Complex220143010.190 Why?
Humans5620196607310.190 Why?
Fluorodeoxyglucose F184201219290.180 Why?
Aged, 80 and over172019576800.180 Why?
PTEN Phosphohydrolase2201711010.180 Why?
Filgrastim220151440.180 Why?
Mouth Neoplasms220155970.180 Why?
Thyroid Neoplasms3201719970.170 Why?
Treatment Outcome142017591490.170 Why?
Indoles1200618790.170 Why?
Cell Hypoxia220097190.160 Why?
Alternative Splicing1200211240.160 Why?
Aminopyridines220173490.150 Why?
Morpholines220175350.150 Why?
Niacinamide120174230.150 Why?
Radiopharmaceuticals5201326230.150 Why?
Administration, Oral2201339110.140 Why?
Folic Acid Antagonists12014770.140 Why?
Adenocarcinoma, Follicular120172760.140 Why?
Phenylurea Compounds120175360.140 Why?
Lymphatic Metastasis6201130300.130 Why?
Iodine Radioisotopes2201710630.130 Why?
Misonidazole22009490.130 Why?
Recombinant Proteins3201570240.130 Why?
Depsipeptides120131030.120 Why?
Leukopenia120122200.120 Why?
Hemoptysis120131470.120 Why?
Fatal Outcome1201719380.120 Why?
Nomograms120142260.120 Why?
Polyethylene Glycols2201511860.120 Why?
Radiotherapy Dosage3201329110.120 Why?
Neoadjuvant Therapy2201321880.110 Why?
Benzimidazoles120178460.110 Why?
Radiation-Sensitizing Agents120134120.110 Why?
Glycolysis220127680.110 Why?
Combined Modality Therapy6201590350.110 Why?
Vitamin B 12120145200.110 Why?
Wounds, Gunshot120164750.110 Why?
Vascular Endothelial Growth Factor A3201334660.110 Why?
Trauma Centers120167910.110 Why?
Lymphoma, B-Cell120178880.110 Why?
Tomography, X-Ray Computed72016201020.110 Why?
Firearms120164520.100 Why?
Cyclin-Dependent Kinase Inhibitor p21120103920.100 Why?
Folic Acid2201412130.100 Why?
Tissue Array Analysis120105810.100 Why?
Carcinoma, Adenoid Cystic120102480.090 Why?
Laryngeal Neoplasms220105290.090 Why?
Orthopedics120166980.090 Why?
Salivary Gland Neoplasms120102420.090 Why?
Prognosis72019280270.090 Why?
Papillomavirus Infections2201712770.080 Why?
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits22004220.080 Why?
Neoplasm Invasiveness2201237560.080 Why?
Probenecid12005760.080 Why?
Thyroid Gland1201311590.080 Why?
Cost of Illness1201617610.080 Why?
Retrospective Studies122019632320.080 Why?
Physical Examination1201112280.070 Why?
Thrombocytopenia1201211120.070 Why?
Hyperglycemia1201212680.070 Why?
Statistics, Nonparametric4201130310.070 Why?
Smoking2201389300.070 Why?
Anemia1201213360.070 Why?
Proto-Oncogene Proteins c-akt1201325100.070 Why?
Phosphatidylinositol 3-Kinases1201326390.070 Why?
Immunotherapy1201833690.070 Why?
Contrast Media3201152870.060 Why?
Young Adult62019540780.060 Why?
Education, Medical, Graduate1201620170.060 Why?
Radiation Tolerance220175560.060 Why?
Large-Conductance Calcium-Activated Potassium Channels12002330.060 Why?
Regional Blood Flow1200616410.060 Why?
Fluorouracil3201415890.060 Why?
Recurrence2201080720.060 Why?
Chemotherapy, Adjuvant1201033850.060 Why?
Potassium Channels120045740.060 Why?
Kaplan-Meier Estimate1201268560.060 Why?
Area Under Curve1200517080.050 Why?
Survival Rate22019132490.050 Why?
Magnetic Resonance Imaging42011320950.050 Why?
Phosphorylation2201087910.050 Why?
Protein Kinases1200816640.050 Why?
Molecular Targeted Therapy1201227310.050 Why?
Lung Neoplasms22013115540.050 Why?
Microtubule-Associated Proteins1200410640.050 Why?
RNA Processing, Post-Transcriptional120024420.050 Why?
Immunohistochemistry22010120570.050 Why?
Deglutition Disorders220155410.050 Why?
Age of Onset1200532730.040 Why?
Lymph Nodes1200933360.040 Why?
Follow-Up Studies62019388750.040 Why?
Gadolinium DTPA220118600.040 Why?
Analysis of Variance3201167540.040 Why?
Patient Selection1201043350.040 Why?
Signal Transduction22013238440.040 Why?
Decision Making1201138400.040 Why?
Louisiana120161150.040 Why?
Flow Cytometry1200762600.040 Why?
Carcinoma, Non-Small-Cell Lung1201343700.040 Why?
Diagnostic Imaging1201133770.040 Why?
Trismus12015370.040 Why?
Ribavirin120173990.040 Why?
Heart Rate1200641660.040 Why?
Mucositis12015920.040 Why?
Prospective Studies32013469490.040 Why?
Disease Progression22014128590.030 Why?
Karnofsky Performance Status120131980.030 Why?
Ultrasonography1200657740.030 Why?
Adenoma, Oxyphilic120131290.030 Why?
Tissue Distribution1201724520.030 Why?
Mutation22017278320.030 Why?
Ovarian Neoplasms1200845410.030 Why?
Cytokines1200770060.030 Why?
Protein Kinase Inhibitors1200849350.030 Why?
Proportional Hazards Models32011121790.030 Why?
Obesity12014113030.030 Why?
Palatal Neoplasms12010420.030 Why?
Whole Body Imaging120132640.030 Why?
Hypopharyngeal Neoplasms12010550.030 Why?
Cohort Studies42017371210.030 Why?
Risk Assessment12013229230.030 Why?
Pharyngeal Neoplasms120101240.030 Why?
Palate, Soft12010970.030 Why?
Xerostomia120101000.030 Why?
Sex Factors12005106780.030 Why?
Survival Analysis22015106020.030 Why?
Blood Pressure1200684080.030 Why?
Endpoint Determination120136370.030 Why?
Risk Factors22014668870.020 Why?
Choline120114660.020 Why?
Radionuclide Imaging1201320280.020 Why?
Nasopharyngeal Neoplasms120112490.020 Why?
New York City120106370.020 Why?
Extracellular Space120116220.020 Why?
Drug Substitution120102670.020 Why?
Cancer Care Facilities120103960.020 Why?
Histone Deacetylase Inhibitors120137690.020 Why?
Biological Transport1201221870.020 Why?
Carcinoma, Papillary120138050.020 Why?
Proto-Oncogene Proteins B-raf1201717830.020 Why?
Salvage Therapy1201412740.020 Why?
Radiation Injuries1201512860.020 Why?
Postoperative Care1201315570.020 Why?
Subtraction Technique120095540.020 Why?
Antiviral Agents1201725240.020 Why?
Creatinine1201018220.020 Why?
Treatment Failure1201026470.020 Why?
Neutropenia120088310.020 Why?
Neck120086730.020 Why?
Precipitin Tests120049130.020 Why?
Two-Hybrid System Techniques120044920.020 Why?
Clinical Trials as Topic2201079740.020 Why?
Glutathione Transferase120046220.020 Why?
Gene Library1200410930.010 Why?
Feasibility Studies1201146520.010 Why?
DNA, Complementary1200421540.010 Why?
Regression Analysis1201166910.010 Why?
Magnetic Resonance Spectroscopy1201136710.010 Why?
Cytoskeleton1200412510.010 Why?
Glucose1201139310.010 Why?
Multivariate Analysis12012127240.010 Why?
Cerebellum1200414480.010 Why?
Adolescent22016827960.010 Why?
Actins1200422240.010 Why?
Emergency Service, Hospital1201668070.010 Why?
Protein Structure, Tertiary1200442130.010 Why?
Dietary Supplements1200828200.010 Why?
Body Mass Index12014119170.010 Why?
Protein Processing, Post-Translational1200420850.010 Why?
Adenocarcinoma1201363770.010 Why?
Recombinant Fusion Proteins1200439450.010 Why?
Infant12016330540.010 Why?
Cell Membrane1200439370.010 Why?
Animals220041685010.010 Why?
Child, Preschool12016402760.010 Why?
Incidence12010197390.010 Why?
Base Sequence12004137410.010 Why?
Hippocampus1200435030.010 Why?
Amino Acid Sequence12004145680.010 Why?
Protein Binding1200498250.010 Why?
Practice Guidelines as Topic1200874850.010 Why?
Molecular Sequence Data12004194320.010 Why?
Child12016687860.010 Why?
Cells, Cultured12004205830.010 Why?
Rats12004254240.010 Why?
United States12012632180.000 Why?
Brain12004233620.000 Why?
Mice12004791080.000 Why?
Fury's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.